Logo image of NCEW

NEW CENTURY LOGISTICS BVI LT (NCEW) Stock Fundamental Analysis

NASDAQ:NCEW - Nasdaq - VGG646271053 - Common Stock - Currency: USD

1.0098  -0.03 (-2.9%)

Fundamental Rating

1

NCEW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 22 industry peers in the Air Freight & Logistics industry. NCEW may be in some trouble as it scores bad on both profitability and health. NCEW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NCEW had positive earnings in the past year.
NCEW Yearly Net Income VS EBIT VS OCF VS FCFNCEW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2024 2M 4M 6M 8M

1.2 Ratios

The profitability ratios for NCEW are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCEW Yearly ROA, ROE, ROICNCEW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2024 20 40 60

1.3 Margins

NCEW has a Profit Margin of 0.42%. This is comparable to the rest of the industry: NCEW outperforms 54.55% of its industry peers.
NCEW's Profit Margin has declined in the last couple of years.
NCEW has a Operating Margin of 0.90%. This is comparable to the rest of the industry: NCEW outperforms 45.45% of its industry peers.
NCEW's Operating Margin has declined in the last couple of years.
NCEW has a Gross Margin of 8.13%. This is in the lower half of the industry: NCEW underperforms 72.73% of its industry peers.
In the last couple of years the Gross Margin of NCEW has declined.
Industry RankSector Rank
OM 0.9%
PM (TTM) 0.42%
GM 8.13%
OM growth 3Y-54.02%
OM growth 5YN/A
PM growth 3Y-62.03%
PM growth 5YN/A
GM growth 3Y-17.01%
GM growth 5YN/A
NCEW Yearly Profit, Operating, Gross MarginsNCEW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2024 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

NCEW does not have a ROIC to compare to the WACC, probably because it is not profitable.
NCEW Yearly Shares OutstandingNCEW Yearly Shares OutstandingYearly Shares Outstanding 2022 5M 10M 15M 20M
NCEW Yearly Total Debt VS Total AssetsNCEW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2024 5M 10M 15M 20M 25M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.85%
NCEW Yearly LT Debt VS Equity VS FCFNCEW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2024 2M 4M 6M 8M 10M

2.3 Liquidity

NCEW has a Current Ratio of 1.46. This is a normal value and indicates that NCEW is financially healthy and should not expect problems in meeting its short term obligations.
NCEW has a Current ratio of 1.46. This is comparable to the rest of the industry: NCEW outperforms 54.55% of its industry peers.
A Quick Ratio of 1.46 indicates that NCEW should not have too much problems paying its short term obligations.
The Quick ratio of NCEW (1.46) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.46
NCEW Yearly Current Assets VS Current LiabilitesNCEW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NCEW have been decreasing by -65.85% on average. This is quite bad
NCEW shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.04% yearly.
EPS 1Y (TTM)N/A
EPS 3Y-65.85%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y-10.04%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCEW Yearly Revenue VS EstimatesNCEW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2024 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.66, the valuation of NCEW can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of NCEW is on the same level as its industry peers.
NCEW is valuated rather expensively when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.66
Fwd PE N/A
NCEW Price Earnings VS Forward Price EarningsNCEW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NCEW's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.52
NCEW Per share dataNCEW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NCEW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEW CENTURY LOGISTICS BVI LT

NASDAQ:NCEW (6/26/2025, 12:51:18 PM)

1.0098

-0.03 (-2.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.71M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.66
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 32.52
EPS(TTM)0.03
EY2.97%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.43
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.9%
PM (TTM) 0.42%
GM 8.13%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-54.02%
OM growth 5YN/A
PM growth 3Y-62.03%
PM growth 5YN/A
GM growth 3Y-17.01%
GM growth 5YN/A
F-ScoreN/A
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.46
Altman-Z N/A
F-ScoreN/A
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y-65.85%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y-10.04%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3Y-58.63%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3Y-31.59%
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3Y-32.07%
OCF growth 5YN/A